Originally published Thursday, January 10, 2008 at 12:00 AM
Omeros plans $115 million IPO
Seattle-based biopharmaceutical company Omeros has filed for an initial public offering of stock, aiming to raise as much as $115 million...
Seattle Times staff
Seattle-based biopharmaceutical company Omeros has filed for an initial public offering of stock, aiming to raise as much as $115 million.
It is the first new IPO filing from a local company this year, and follows a rocky 2007 during which more initial offerings were withdrawn than were completed.
The company, founded in 1994, has no product revenue and no products approved for marketing.
It is developing compounds for inflammation and disorders of the central nervous system, specifically low-dosage proprietary combinations of therapeutic drugs that are delivered during surgery.
Its most advanced product candidates are targeted at arthroscopic, ophthalmological and urological surgery.
Proceeds of the IPO would be used, in part, to complete Phase 3 clinical trials of its leading candidate.
Omeros has spent $72 million since its inception, and had $27 million in available cash as of Sept. 30, according to the company's preliminary filing with the Securities and Exchange Commission.
The company did not give an estimated price or number of shares for its proposed offering, which is being underwritten by Deutsche Bank Securities, Pacific Growth Equities, Leerink Swann and Needham & Company.
Copyright © 2008 The Seattle Times Company
Tech execs double as scourges and sages at Allen & Co.'s media summit
UPDATE - 06:56 AM
Stocks fall amid recession worries
UPDATE - 07:03 AM
Bankruptcy judge OKs GM sale plan
Brier Dudley: Brier Dudley | Learning hard lessons from Boeing giveaways

2009 fireworks time lapse
With strict parking rules enforced at this year's July 4th celebration on Wallingford Ave North, less cars and more spectators filled the streets.
Entertainment | Top Video | World | Offbeat Video | Sci-Tech
nwjobs

Post a comment

Michelle Goodman blogs about work/life balance.
Tax tips for new independent professionals
Post a comment
nwautos

Choosing a new truck? Weigh the impact of your choice on your wallet and on the planet.
Post a comment
nwhomes

Find a new home or condo that fits your lifestyle.
Search New Developments
Builder Directory
- Landmark Smith Tower mostly vacant
- Property taxes: Appeals shoot up in King, Snohomish Counties
- Palin links resignation to 'higher calling' and blasts media in Facebook posting
- Shooting unveils very different sides of McNair
- Former NFL MVP McNair killed
- Hard times for tourist towns means good deals for travelers
- Tukwila residents rally against light-rail noise
- Quincy Jones remembers "the biggest entertainer on the planet": Michael Jackson
- Confessions of an Idol Addict | "American Idols" on tour: Live coverage from opening date
- Plasma and LCD beware; OLED screens ready to go mainstream
- Seattle Mariners at Boston Red Sox: 07/05 game thread
247 - Palin links resignation to 'higher calling' and blasts media in Facebook posting
179 - Hatred for the NBA runs deep, but don't take it out on the players
137 - Tukwila residents rally against light-rail noise
128 - Former NFL MVP McNair killed
113 - Property taxes: Appeals shoot up is King, Snohomish Counties
103 - Tent City on campus: UW stalls decision
101 - Anti-tax rally in Olympia attracts about 1,500
68 - Mariners did their part, now they need help
46 - Megachurch pastor Rick Warren addresses US Muslims
36
- Property taxes: Appeals shoot up in King, Snohomish Counties
- Hard times for tourist towns means good deals for travelers
- Landmark Smith Tower mostly vacant
- Plasma and LCD beware; OLED screens ready to go mainstream
- The People's Pharmacy | Estrogen mimicker found in sunscreen
- Tent City on campus: UW stalls decision
- Toyota's Toyoda scolds execs for emulating U.S. car companies' mistakes
- Tukwila residents rally against light-rail noise
- Outdoor-theater season kicks off at Volunteer Park
- Seattle safety project: A snake shelter on Beacon Hill





